文献速递治疗药物监测与药物基因组学

临床药师如何为患者解读多基因药物基因组学检测结果

A clinician's guide for counseling patients on results of a multigene pharmacogenomic panel.
PubMed 文献 · Am J Health Syst Pharm · 2022-01-01

本文基于5家机构药师的实践经验,探讨多基因药物基因组学检测结果的患者咨询方法。文章总结了结果披露时的核心咨询主题,包括药物基因组学结果、基因-药物相互作用、药物调整及未来风险等。作者强调应投入时间进行患者咨询,因该检测通常仅做一次但具有终身应用价值。

要点

  • 多基因药物基因组学检测结果咨询应涵盖8个核心主题,包括结果解读、基因-药物相互作用及药物调整等。
  • 咨询需关注基因-药物-药物相互作用及未来、家族或疾病风险 implications。
  • 应评估患者理解程度并分享结果与补充信息,且需定期更新解读。

核心结论

  • 鉴于多基因药物基因组学检测通常仅进行一次且具有终身应用价值,投入时间进行患者咨询十分重要。
  • 5家机构药师的咨询内容与方法可作为指南,待有效沟通策略研究进一步细化。

研究设计与样本

  • 本文通过描述5家机构药物基因组学诊所药师的集体经验,探讨多基因面板检测后的药物基因组学咨询方法。
  • 文中比较了来自5个不同机构药师的咨询实践,经验涵盖从学术到社区临床环境。

主要发现

  • 结果披露时讨论的总体咨询主题包括:药物基因组学结果、基因-药物相互作用、基因-药物-药物相互作用、药物调整、未来/家族/疾病风险影响、药物基因组学结果解读与应用的更新、评估患者理解程度、分享结果与补充信息。
  • 已发表的关于药物基因组学检测结果披露的文献有限。

临床怎么用

  • 临床药师在为患者解读多基因药物基因组学面板结果时,可参考上述8个核心咨询主题组织咨询内容。
  • 咨询中应评估患者对结果的 comprehension,并分享结果与补充信息。
  • 需关注药物基因组学结果解读与应用的更新,以便为患者提供最新信息。

局限性

  • 已发表的关于药物基因组学检测结果披露的文献有限。
  • 所分享的咨询内容与方法需待研究进一步细化,以形成有效沟通策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This article explores approaches to pharmacogenomic counseling for patients who have undergone multigene panel testing by describing the collective experience of 5 institutions. SUMMARY: Multigene panel pharmacogenomic testing has the potential to unlock a myriad of information about a patient's past, present, and future drug response. The multifaceted nature of drug response coupled with the complexity of genetic results necessitates some form of patient education through pharmacogenomic counseling. Published literature regarding disclosure of pharmacogenomic test results is limited. This article compares the counseling practices of pharmacists from 5 different institutions with pharmacogenomics clinics whose experience represents perspectives ranging from academia to community clinical environments. Overarching counseling themes discussed during result disclosure center around (1) pharmacogenomic results, (2) gene-drug interactions, (3) gene-drug-drug interactions, (4) drug changes (5) future, familial, or disease-risk implications, (6) updates in the interpretation and application of pharmacogenomic results, (7) gauging patient comprehension, and (8) sharing results and supplemental information. CONCLUSION: Dedicating time to counseling patients on the results of a multigene pharmacogenomic panel is important given the lifelong applications of a test that is generally performed only once. The content and methods of disclosing test results shared by the experiences of pharmacists at 5 different institutions serve as guide to be further refined as research addresses effective communication strategies that enhance patient comprehension of pharmacogenomic results.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Ho TT, Bell G, Gammal RS, et al. A clinician's guide for counseling patients on results of a multigene pharmacogenomic panel. Am J Health Syst Pharm. 2022. PMID: 35876085. doi:10.1093/ajhp/zxac189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。